Has Stephanie Gee, OD received payments from drug or device companies?

Yes. Drug and device makers reported $3,537 in general payments to Stephanie Gee, OD across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephanie Gee, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephanie Gee, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephanie Gee, OD

Optometrist · Sacaton, AZNPI 1578122925

Payments from drug & device makers

$3,537in general payments, 2019–2025

Across 31 payments — averaging $114.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$2K
Johnson & Johnson Vision Care, Inc.$461
Coopervision Inc.$354
Biotissue Holdings Inc.$167
Bausch & Lomb, A Division Of Bausch Health US, LLC$159
Bausch & Lomb Americas Inc.$156
plus $67 from 2 others

What the payments were for

Consulting fees$70020%
Speaking & faculty fees$35010%
Travel & lodging$1,11732%
Food & beverage$1,37039%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	12	$2,173
Johnson & Johnson Vision Care, Inc.	5	$461
Coopervision Inc.	4	$354
Biotissue Holdings Inc.	3	$167
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$159
Bausch & Lomb Americas Inc.	2	$156
Thea Pharma Inc.	1	$34
Novartis	2	$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,537 in reported general payments places this provider in the 85th percentile of 1,134 optometrist providers in Arizona.

See all optometrist providers in Arizona →

Medicare billing

Part B allowed, 2024

$28,579

Medicare patients

196

Services billed

548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CombiganBrimonidine Tartrate/Timolol	13	$2,518
Latanoprost	33	$293

Paid to pharmacies, not to this prescriber.

Other optometrist in Sacaton

Kevin HelmuthSacaton$281K
Marc BloomensteinScottsdale$2.3M
Stephanie WooLake Havasu City$540K
Christina SorensonGlendale$181K
Jashpal RajasansiGilbert$120K
Michelle Marie MijaresFort Defiance$38K
Jamie KuhnGlendale$37K
Tania SobchukLake Havasu City$32K
Stephen CohenScottsdale$32K
Florencia YehGlendale$28K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →